2019 Q1 Form 10-Q Financial Statement
#000156459019017255 Filed on May 08, 2019
Income Statement
Concept | 2019 Q1 | 2018 Q1 |
---|---|---|
Revenue | $8.071M | $12.64M |
YoY Change | -36.13% | 268.96% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $17.12M | $10.09M |
YoY Change | 69.67% | 38.6% |
% of Gross Profit | ||
Research & Development | $34.85M | $23.55M |
YoY Change | 48.0% | 81.94% |
% of Gross Profit | ||
Depreciation & Amortization | $715.0K | $588.0K |
YoY Change | 21.6% | 95.35% |
% of Gross Profit | ||
Operating Expenses | $51.97M | $33.63M |
YoY Change | 54.51% | 66.36% |
Operating Profit | -$43.90M | -$21.00M |
YoY Change | 109.06% | 25.04% |
Interest Expense | $1.690M | $810.0K |
YoY Change | 108.64% | 406.25% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | -$42.20M | -$20.19M |
YoY Change | 109.01% | 21.41% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$42.15M | -$20.19M |
YoY Change | 108.8% | 21.37% |
Net Earnings / Revenue | -522.24% | -159.75% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$412.1K | -$233.9K |
COMMON SHARES | ||
Basic Shares Outstanding | 102.3M | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q1 | 2018 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $351.0M | $229.5M |
YoY Change | 52.94% | 77.49% |
Cash & Equivalents | $80.97M | $34.21M |
Short-Term Investments | $270.0M | $198.8M |
Other Short-Term Assets | $3.700M | $2.800M |
YoY Change | 32.14% | 64.71% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $7.300M | $3.600M |
Other Receivables | $600.0K | $300.0K |
Total Short-Term Assets | $362.6M | $236.3M |
YoY Change | 53.45% | 76.61% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $46.50M | $33.60M |
YoY Change | 38.39% | 360.27% |
Goodwill | ||
YoY Change | ||
Intangibles | $53.17M | |
YoY Change | ||
Long-Term Investments | $5.000M | |
YoY Change | 66.67% | |
Other Assets | $41.20M | $4.700M |
YoY Change | 776.6% | 291.67% |
Total Long-Term Assets | $180.1M | $44.90M |
YoY Change | 301.11% | 245.38% |
TOTAL ASSETS | ||
Total Short-Term Assets | $362.6M | $236.3M |
Total Long-Term Assets | $180.1M | $44.90M |
Total Assets | $542.7M | $281.2M |
YoY Change | 92.99% | 91.55% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $30.10M | $11.00M |
YoY Change | 173.64% | 48.65% |
Accrued Expenses | $6.200M | $3.200M |
YoY Change | 93.75% | 60.0% |
Deferred Revenue | $54.82M | |
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $91.10M | $49.40M |
YoY Change | 84.41% | 277.1% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $25.40M |
YoY Change | -100.0% | 551.28% |
Other Long-Term Liabilities | $1.911M | $24.00M |
YoY Change | -92.04% | 485.37% |
Total Long-Term Liabilities | $1.911M | $49.40M |
YoY Change | -96.13% | 517.5% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $91.10M | $49.40M |
Total Long-Term Liabilities | $1.911M | $49.40M |
Total Liabilities | $214.2M | $98.80M |
YoY Change | 116.8% | 368.26% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$514.5M | |
YoY Change | ||
Common Stock | $697.3M | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $328.5M | $182.4M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $542.7M | $281.2M |
YoY Change | 93.03% | 91.53% |
Cashflow Statement
Concept | 2019 Q1 | 2018 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$42.15M | -$20.19M |
YoY Change | 108.8% | 21.37% |
Depreciation, Depletion And Amortization | $715.0K | $588.0K |
YoY Change | 21.6% | 95.35% |
Cash From Operating Activities | -$45.12M | -$18.13M |
YoY Change | 148.81% | 38.43% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $5.977M | $2.616M |
YoY Change | 128.48% | 458.97% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$8.800M | -$9.000M |
YoY Change | -2.22% | -238.46% |
Cash From Investing Activities | -$14.80M | -$11.57M |
YoY Change | 27.94% | -289.62% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $481.0K | $10.60M |
YoY Change | -95.46% | 45973.91% |
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $216.0K | 10.58M |
YoY Change | -97.96% | 211.26% |
NET CHANGE | ||
Cash From Operating Activities | -$45.12M | -18.13M |
Cash From Investing Activities | -$14.80M | -11.57M |
Cash From Financing Activities | $216.0K | 10.58M |
Net Change In Cash | -$59.45M | -19.12M |
YoY Change | 210.96% | 431.06% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$45.12M | -$18.13M |
Capital Expenditures | $5.977M | $2.616M |
Free Cash Flow | -$51.10M | -$20.75M |
YoY Change | 146.25% | 52.93% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
542729000 | |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
590395000 | |
CY2019Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1022000 | |
CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
929632000 | |
CY2019Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
100639000 | |
CY2018Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
108273000 | |
CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
13299000 | |
CY2018Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
27689000 | |
CY2018Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
6705000 | |
CY2019Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1911000 | |
CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1960000 | |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-562696000 | |
CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1440000 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
366518000 | |
CY2019Q1 | us-gaap |
Minority Interest
MinorityInterest
|
686000 | |
CY2018Q4 | us-gaap |
Minority Interest
MinorityInterest
|
739000 | |
CY2019Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
329181000 | |
CY2018Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
367257000 | |
CY2019Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
53170000 | |
CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
54243000 | |
CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
28190000 | |
CY2019Q1 | us-gaap |
Prepaid Rent
PrepaidRent
|
33559000 | |
CY2019Q1 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
3500000 | |
CY2018Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
3500000 | |
CY2019Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
54824000 | |
CY2018Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
47564000 | |
CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
102270000 | |
CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
86334000 | |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-1504000 | |
CY2018Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
182365000 | |
CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
715000 | |
CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
253000 | |
CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
51968000 | |
CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
33634000 | |
CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-99000 | |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-43454000 | |
CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-20286000 | |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-53000 | |
CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
588000 | |
CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1238000 | |
CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-43897000 | |
CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20997000 | |
CY2019Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
1694000 | |
CY2018Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
810000 | |
CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-42203000 | |
CY2018Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-20187000 | |
CY2019Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-53000 | |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42150000 | |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20187000 | |
CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.41 | |
CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.23 | |
CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-20286000 | |
CY2019Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
216000 | |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
258000 | |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4523000 | |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
1504000 | |
CY2017Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
187900000 | |
CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3050000 | |
CY2018Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
459000 | |
CY2019Q1 | sgmo |
Gain On Free Shares
GainOnFreeShares
|
545000 | |
CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4523000 | |
CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3050000 | |
CY2018Q1 | sgmo |
Build To Suit Leases
BuildToSuitLeases
|
-217000 | |
CY2019Q1 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
-218000 | |
CY2019Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-44000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
219000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
133000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2638000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
232000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1152000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1334000 | |
CY2019Q1 | sgmo |
Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
|
-782000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
12101000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
10183000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-77000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-3306000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2268000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-370000 | |
CY2018Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
2701000 | |
CY2019Q1 | sgmo |
Increase Decrease In Long Term Portion Of Lease Liabilities
IncreaseDecreaseInLongTermPortionOfLeaseLiabilities
|
-66000 | |
CY2018Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
63401000 | |
CY2019Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
78253000 | |
CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
54450000 | |
CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5977000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-50000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-45119000 | |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18134000 | |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-11567000 | |
CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2616000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-14799000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
216000 | |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10583000 | |
CY2019Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
87075000 | |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
53326000 | |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
84468000 | |
CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
34208000 | |
CY2019Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
252000 | |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-59450000 | |
CY2019Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
265000 | |
CY2018Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
14000 | |
CY2019Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
481000 | |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10597000 | |
CY2019Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
6676000 | |
CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-19118000 | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
143918000 | |
CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.67%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. In March 2019, the Company recorded an adjustment to revenue related to a change in estimate in connection with the hemophilia A collaboration agreement with Pfizer Inc. (“Pfizer”) as result of a decision made in a joint steering committee of Pfizer and Sangamo in March 2019 to increase the project scope and related project cost, which resulted in a decrease in the measure of the proportional performance. This adjustment decreased revenue by $3.0 million, increased net loss by $3.0 million and increased the Company’s basic net loss per share by $0.03 for the three months ended March 31, 2019.</p> | |
CY2019Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.67%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts in the accompanying condensed consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations. The Company reclassified $0.6 million from Intangible assets to Other non-current assets on the Condensed Consolidated Balance Sheet as of December 31, 2018.</p> | |
CY2019Q1 | sgmo |
Cash Equivalent Maturity Period Highly Liquid Investment
CashEquivalentMaturityPeriodHighlyLiquidInvestment
|
three months or less | |
CY2018Q4 | sgmo |
Deferred Rent Noncurrent
DeferredRentNoncurrent
|
271000 | |
CY2019Q1 | us-gaap |
Share Price
SharePrice
|
9.54 | |
CY2018Q4 | us-gaap |
Share Price
SharePrice
|
11.48 | |
CY2019Q1 | us-gaap |
Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
|
0.89 | |
CY2018Q4 | us-gaap |
Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
|
0.87 | |
CY2019Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
270034000 | |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
259974000 | |
CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
19000 | |
CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
25000 | |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
259000 | |
CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
270028000 | |
CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
259715000 | |
CY2019Q1 | sgmo |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
290257000 | |
CY2018Q4 | sgmo |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
363265000 | |
CY2019Q1 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax
|
19000 | |
CY2019Q1 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
|
25000 | |
CY2018Q4 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
|
259000 | |
CY2019Q1 | sgmo |
Cash Equivalents And Available For Sale Securities
CashEquivalentsAndAvailableForSaleSecurities
|
290251000 | |
CY2018Q4 | sgmo |
Cash Equivalents And Available For Sale Securities
CashEquivalentsAndAvailableForSaleSecurities
|
363006000 | |
CY2019Q1 | sgmo |
Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
|
P1Y | |
CY2018 | sgmo |
Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
|
P1Y | |
CY2019Q1 | us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | |
CY2018Q1 | us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | |
CY2019Q1 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
CY2018Q4 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
CY2019Q1 | sgmo |
Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstandingNumber
|
11604633 | |
CY2018Q1 | sgmo |
Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstandingNumber
|
8858623 | |
CY2014Q1 | sgmo |
Number Of Research Program
NumberOfResearchProgram
|
2 | |
CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4523000 | |
CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3050000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1200000 | |
CY2019Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
200000 | |
CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
500000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1845000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
3177000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
3163000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
3173000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
3240000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
14687000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
29285000 | |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
7850000 | |
CY2019Q1 | sgmo |
Lessee Operating Lease Liability Tenant Improvement Allowance
LesseeOperatingLeaseLiabilityTenantImprovementAllowance
|
6816000 | |
CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
14619000 | |
CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1320000 | |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P9Y | |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.069 | |
CY2019Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2018 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2018Q4 | us-gaap |
Business Acquisition Share Price
BusinessAcquisitionSharePrice
|
2.99 | |
CY2018Q4 | sgmo |
Business Acquisition Number Of Shares Owned By Sellers Under Block Transaction
BusinessAcquisitionNumberOfSharesOwnedBySellersUnderBlockTransaction
|
11981867 | |
CY2018Q4 | us-gaap |
Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
|
35829000 | |
CY2018 | sgmo |
Post Business Acquisition Shares Acquired Amount
PostBusinessAcquisitionSharesAcquiredAmount
|
34516000 | |
CY2018 | us-gaap |
Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
|
1313000 | |
CY2018 | sgmo |
Noncontrolling Interest Increase Decrease From Foreign Currency Effect
NoncontrollingInterestIncreaseDecreaseFromForeignCurrencyEffect
|
-19000 | |
CY2018 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-555000 |